BackUniversal Ibogaine Overview

Universal Ibogaine Current Cash

Latest current cash for IBOGF: $130K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$127746.00
↓ 72.83% YoYΔ $-342368.00 vs prior year quarter

Peer trimmed avg / median

Loading

Universal Ibogaine Current Cash History

Loading

Universal Ibogaine vs. peers: Current Cash Comparison

Loading

Universal Ibogaine Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Universal Ibogaine (IBOGF) FAQ

The latest current cash for IBOGF is $130K as of April 2025. That compares with $470K in the prior-year period — down 72.8% year over year. Investors often review this figure alongside Universal Ibogaine's historical trend and sector peers before judging valuation or financial health.

Over the past year, IBOGF's current cash moved from $470K to $130K — a 72.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Universal Ibogaine's operating scale or balance-sheet position.

A current cash figure of $130K for IBOGF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IBOGF's current cash ($130K), review year-over-year change from $470K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Universal Ibogaine's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.